Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
tanespimycin heat shock protein hsp 90-alpha small molecule NA drugbank , DGIDB leukemia[MeSHID:D007938]
Neoplasms[MeSHID:D009369]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Multiple Myeloma[MeSHID:D009101]
Malignant neoplasm of breast[MeSHID:D001943]		 0.36 investigational inhibitor
tanespimycin heat shock protein hsp 90-alpha small molecule NA drugbank , DGIDB leukemia[MeSHID:D007938]
Neoplasms[MeSHID:D009369]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Multiple Myeloma[MeSHID:D009101]
Malignant neoplasm of breast[MeSHID:D001943]		 0.36 investigational unknown
tanespimycin heat shock protein 90 alpha NA Successful target TTD , DGIDB leukemia[MeSHID:D007938]
Neoplasms[MeSHID:D009369]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Multiple Myeloma[MeSHID:D009101]
Malignant neoplasm of breast[MeSHID:D001943]		 0.36 phase 2 inhibitor
tanespimycin heat shock protein 90 alpha NA Successful target TTD , DGIDB leukemia[MeSHID:D007938]
Neoplasms[MeSHID:D009369]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Multiple Myeloma[MeSHID:D009101]
Malignant neoplasm of breast[MeSHID:D001943]		 0.36 phase 2 unknown
tanespimycin heat shock protein hsp 90-beta small molecule NA drugbank , DGIDB leukemia[MeSHID:D007938]
Neoplasms[MeSHID:D009369]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Multiple Myeloma[MeSHID:D009101]
Malignant neoplasm of breast[MeSHID:D001943]		 1.29 investigational inhibitor
tanespimycin heat shock protein hsp 90-beta small molecule NA drugbank , DGIDB leukemia[MeSHID:D007938]
Neoplasms[MeSHID:D009369]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Multiple Myeloma[MeSHID:D009101]
Malignant neoplasm of breast[MeSHID:D001943]		 1.29 investigational unknown
click here to return to the previous page